Crescendo Health Names Experienced Industry Leader as Chief Scientific Officer

Crescendo Health has appointed David Strutton as its new Chief Scientific Officer. Strutton brings decades of experience in clinical research, real-world evidence, and health economics to his role.

He joins Crescendo from Pfizer, where he led the Vaccines Global Health and Value team, generating evidence to support vaccine access globally. At Merck, he played a key role in establishing the Center for Observational and Real-World Evidence (CORE).

'Dave's deep scientific rigor and leadership in observational research make him the ideal leader to advance our methodologies,' said Crescendo Health CEO Sam Roosz.